Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

May 28, 2002

Primary Completion Date

July 19, 2011

Study Completion Date

July 19, 2011

Conditions
Lung Cancer, Non-Small Cell
Interventions
BIOLOGICAL

GSK 249553 vaccine

Intramuscular injection, 13 doses

BIOLOGICAL

Placebo

Intramuscular administration, 13 doses

Trial Locations (62)

1200

GSK Investigational Site, Brussels

2650

GSK Investigational Site, Edegem

3000

GSK Investigational Site, Leuven

7006

GSK Investigational Site, Trondheim

9000

GSK Investigational Site, Ghent

13419

GSK Investigational Site, Tallinn

14109

GSK Investigational Site, Berlin

15006

GSK Investigational Site, A Coruña

15125

GSK Investigational Site, Marousi

16132

GSK Investigational Site, Genoa

22927

GSK Investigational Site, Großhansdorf

26504

GSK Investigational Site, Rio-Patras

27753

GSK Investigational Site, Delmenhorst

28035

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Madrid

28047

GSK Investigational Site, Madrid

30122

GSK Investigational Site, Venezia

33006

GSK Investigational Site, Oviedo

33100

GSK Investigational Site, Udine

33170

GSK Investigational Site, Pordenone

33520

GSK Investigational Site, Tampere

33600

GSK Investigational Site, Pessac

35033

GSK Investigational Site, Rennes

38008

GSK Investigational Site, Santander

46010

GSK Investigational Site, Valencia

51014

GSK Investigational Site, Tartu

55131

GSK Investigational Site, Mainz

57010

GSK Investigational Site, Thessaloniki

58455

GSK Investigational Site, Witten

58675

GSK Investigational Site, Hemer

60488

GSK Investigational Site, Frankfurt am Main

63069

GSK Investigational Site, Offenbach

67655

GSK Investigational Site, Kaiserslautern

69126

GSK Investigational Site, Heidelberg

78050

GSK Investigational Site, Villingen-Schwenningen

79106

GSK Investigational Site, Freiburg im Breisgau

81675

GSK Investigational Site, Munich

82131

GSK Investigational Site, Gauting

96250

GSK Investigational Site, Ebensfeld

99437

GSK Investigational Site, Bad Berka

00029

GSK Investigational Site, Helsinki

04129

GSK Investigational Site, Leipzig

06114

GSK Investigational Site, Halle

06120

GSK Investigational Site, Halle

06156

GSK Investigational Site, Perugia

LV 1002

GSK Investigational Site, Riga

LV 2118

GSK Investigational Site, Rigas Rajons

LT-01102

GSK Investigational Site, Vilnius

Unknown

GSK Investigational Site, Amsterdam

GSK Investigational Site, Oslo

GSK Investigational Site, Tuszyn

GSK Investigational Site, Warsaw

GSK Investigational Site

6525 GA

GSK Investigational Site, Nijmegen

26-060

GSK Investigational Site, Chęciny

80-211

GSK Investigational Site, Gdansk

60-569

GSK Investigational Site, Poznan

34-500

GSK Investigational Site, Zakopane

08036

GSK Investigational Site, Barcelona

07014

GSK Investigational Site, Palma de Mallorca

HU8 9HE

GSK Investigational Site, Hull

SE1 9RS

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY